# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Fibrodysplasia Ossificans Progressiva
- **MONDO ID:**  (if available)
- **Category:** Genetic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Fibrodysplasia Ossificans Progressiva**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** perplexity
**Generated:** 2025-12-16T19:12:05.942806

1. https://www.ncbi.nlm.nih.gov/books/NBK576373/
2. http://www.fopitalia.it/files/Pubblicazione-Ravazzolo-Bocciardi-2021.pdf
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC11353020/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC3484858/
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC11048698/
6. https://boa.unimib.it/handle/10281/461764
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC4829946/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC10967946/
9. https://rarediseases.org/rare-diseases/fibrodysplasia-ossificans-progressiva/
10. https://www.ncbi.nlm.nih.gov/books/NBK558090/
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC4898187/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC3515059/
13. https://www.pnas.org/doi/10.1073/pnas.1302703111
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC8760285/
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC9068236/
16. https://pmc.ncbi.nlm.nih.gov/articles/PMC6002476/
17. https://www.nature.com/articles/s41467-018-06068-6
18. https://pmc.ncbi.nlm.nih.gov/articles/PMC5010462/
19. https://www.nature.com/articles/s41598-024-60717-z
20. https://elifesciences.org/articles/53761
21. https://pmc.ncbi.nlm.nih.gov/articles/PMC10887042/
22. https://pmc.ncbi.nlm.nih.gov/articles/PMC6627015/
23. https://pmc.ncbi.nlm.nih.gov/articles/PMC4687587/
24. https://pmc.ncbi.nlm.nih.gov/articles/PMC5735276/
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC2663346/
26. https://pmc.ncbi.nlm.nih.gov/articles/PMC10968511/
27. https://medlineplus.gov/genetics/condition/fibrodysplasia-ossificans-progressiva/
28. https://pmc.ncbi.nlm.nih.gov/articles/PMC3502040/
29. https://pubmed.ncbi.nlm.nih.gov/24677724/
30. https://pubmed.ncbi.nlm.nih.gov/28473268/
31. https://pmc.ncbi.nlm.nih.gov/articles/PMC9448829/
32. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.637011/full
33. https://www.orpha.net/en/disease/detail/337
34. https://www.childrenshospital.org/conditions-treatments/thoracic-insufficiency-syndrome
35. https://pmc.ncbi.nlm.nih.gov/articles/PMC3752395/
36. https://www.jci.org/articles/view/42285
37. https://pmc.ncbi.nlm.nih.gov/articles/PMC10731142/
38. https://pmc.ncbi.nlm.nih.gov/articles/PMC7911104/
39. https://pmc.ncbi.nlm.nih.gov/articles/PMC4858538/
40. https://pmc.ncbi.nlm.nih.gov/articles/PMC6533435/
41. https://pubmed.ncbi.nlm.nih.gov/33572801/
42. https://pubmed.ncbi.nlm.nih.gov/25122769/
43. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2017.00047/full
44. https://pmc.ncbi.nlm.nih.gov/articles/PMC3627420/
45. https://pmc.ncbi.nlm.nih.gov/articles/PMC305260/
46. https://www.nature.com/articles/s41419-023-06192-2
47. https://www.nature.com/articles/s41413-020-00119-9
48. https://pmc.ncbi.nlm.nih.gov/articles/PMC7036122/
49. https://www.pnas.org/doi/10.1073/pnas.2019152118
50. https://now.aapmr.org/heterotopic-ossifications/
51. https://elifesciences.org/articles/65910
52. https://pmc.ncbi.nlm.nih.gov/articles/PMC6956855/
53. https://pmc.ncbi.nlm.nih.gov/articles/PMC3978825/
54. https://pmc.ncbi.nlm.nih.gov/articles/PMC9695818/
55. https://pmc.ncbi.nlm.nih.gov/articles/PMC2921861/
56. https://www.nature.com/articles/boneres20169
57. https://pmc.ncbi.nlm.nih.gov/articles/PMC4422812/
58. https://www.nature.com/articles/boneres20165